Skip to main content
Menu
US

IVISense Edema 680 Fluorescent Probe (Superhance)

IVISense™ Edema (Superhance™ 680) fluorescent probe is a blood pooling imaging agent for imaging circulation, blood vessels, vasculature, vascular leak, including that associated with early oncologic and ophthalmologic lesions. This agent has a short pharmacokinetic profile with bladder clearance, and binds to albumin in blood for a modestly extended (30m-1h) circulation half-life.

For research use only. Not for use in diagnostic procedures.

For research use only. Not for use in diagnostic procedures.

Feature Specification
Wave Length 680 nm

IVISense™ Edema (Superhance™ 680) fluorescent probe is a blood pooling imaging agent for imaging circulation, blood vessels, vasculature, vascular leak, including that associated with early oncologic and ophthalmologic lesions. This agent has a short pharmacokinetic profile with bladder clearance, and binds to albumin in blood for a modestly extended (30m-1h) circulation half-life.

For research use only. Not for use in diagnostic procedures.

For research use only. Not for use in diagnostic procedures.

Product Variant
Unit Size: 1 Vial (10 doses)
Part #:
NEV10116
List Price
USD 584.21

Overview

IVISense Edema fluorescent probe is a small molecule near infrared fluorescent probe designed for in vivo preclinical intravenous administration. This probe, being of low molecular weight, will leak and pool in regions of acute edema or vascular leak associated with oncology or other diseases. It is ideal for imaging vascularity, perfusion, and vascular permeability.

Benefits of IVISense Edema 680 fluorescent probe:

  • Small molecule fluorescent in vivo edema and vascular leak imaging agent.
  • Short pharmacokinetic profile, extended modestly by albumin binding moiety to improve performance (30m-1h blood half-life).
  • For imaging of acute changes in vascularity, perfusion, and vascular permeability.
  • Enables sensitive imaging and detection of vascular leak, including that associated with early inflammatory, oncologic, and opthalmologic lesions.

Specifications

Brand
IVISense
Fluorescent Agent Type
Vascular
Imaging Modality
Fluorescence
Shipping Conditions
Shipped Ambient
Therapeutic Area
Angiogenesis
Inflammation
Oncology/Cancer
Vascular disease
Unit Size
1 Vial (10 doses)
Wave Length
680 nm

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Whitepaper Icon
Whitepaper
Understanding the ‘how’ and ‘why’ of spectral unmixing

In vivo fluorescence imaging displays a very broad utility and has become a well-established modality for functional imaging in...

Scroll Icon